ANVISA-2020-0085-V385

Minor variation for application ANVISA-2020-0085. Minor variation: Analytical Method Change for Tisagenlecleux-B — critical change

Variation Number
ANVISA-2020-0085-V385
Type
Minor
Application
ANVISA-2020-0085
Change
CHG-2024-0085
Status
Failed
Fee
€3,393
Submitted
2022-09-11
Approved
—
Description

Minor variation: Analytical Method Change for Tisagenlecleux-B — critical change